Dana-Farber Cancer Research, Teaching Affiliate, Harvard Medical School
World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us
Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved!
New CAR-T Therapy CB-010, Granted Two FDA Designations And Three Patients Are Cancer-Free For Six Months!
What To Eat To Control Blood Sugar
Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!
